TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dr. Monika Serke, MD
Lungenklinik Hemer, D-58675 Hemer, Germany
Study Chair - Gunther Wiest, MD
Asklepios Klinik Harburg, D-21075 Hamburg, Germany
Principal Investigator - Prof. Dr. Martin Wolf, MD
Klinikum Kassel GmbH, D-34125 Kassel
Study Chair - Prof. Dr. Michael Thomas, MD
Thoraxklinik Heidelberg, D-69126 Heidelberg, Germany
Study Chair - Rudolf M. Huber, MD
Klinikum der Universität München, D-80336 München, Germany
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- —
- Last update posted
- 11 Oct 2013
- Registered enrollment
- 0
- Registry id
- NCT01674738
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.